These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A review of tuberculosis: Focus on bedaquiline. Chan B; Khadem TM; Brown J Am J Health Syst Pharm; 2013 Nov; 70(22):1984-94. PubMed ID: 24173008 [TBL] [Abstract][Full Text] [Related]
27. Bedaquiline in MDR/XDR-TB cases: first experience on compassionate use. Tiberi S; De Lorenzo S; Centis R; Viggiani P; D'Ambrosio L; Migliori GB Eur Respir J; 2014 Jan; 43(1):289-92. PubMed ID: 23988772 [No Abstract] [Full Text] [Related]
28. Bedaquiline Microheteroresistance after Cessation of Tuberculosis Treatment. de Vos M; Ley SD; Wiggins KB; Derendinger B; Dippenaar A; Grobbelaar M; Reuter A; Dolby T; Burns S; Schito M; Engelthaler DM; Metcalfe J; Theron G; van Rie A; Posey J; Warren R; Cox H N Engl J Med; 2019 May; 380(22):2178-2180. PubMed ID: 31141643 [No Abstract] [Full Text] [Related]
29. Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis. Mbuagbaw L; Guglielmetti L; Hewison C; Bakare N; Bastard M; Caumes E; Fréchet-Jachym M; Robert J; Veziris N; Khachatryan N; Kotrikadze T; Hayrapetyan A; Avaliani Z; Schünemann HJ; Lienhardt C Emerg Infect Dis; 2019 May; 25(5):936-943. PubMed ID: 31002070 [TBL] [Abstract][Full Text] [Related]
30. The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report. Park S; Lee KM; Kim I; Mok J Int J Infect Dis; 2018 Nov; 76():88-90. PubMed ID: 30244076 [TBL] [Abstract][Full Text] [Related]
31. Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon. Andres S; Merker M; Heyckendorf J; Kalsdorf B; Rumetshofer R; Indra A; Hofmann-Thiel S; Hoffmann H; Lange C; Niemann S; Maurer FP Am J Respir Crit Care Med; 2020 Jun; 201(12):1564-1568. PubMed ID: 32053752 [No Abstract] [Full Text] [Related]
32. Current issues with the use of bedaquiline. Kakkar AK; Dahiya N Ann Pharmacother; 2014 May; 48(5):666. PubMed ID: 24519480 [No Abstract] [Full Text] [Related]
33. Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis. Kunkel A; Cobelens FG; Cohen T PLoS Med; 2016 Oct; 13(10):e1002142. PubMed ID: 27727274 [TBL] [Abstract][Full Text] [Related]
34. Improved Treatment Outcomes With Bedaquiline When Substituted for Second-line Injectable Agents in Multidrug-resistant Tuberculosis: A Retrospective Cohort Study. Zhao Y; Fox T; Manning K; Stewart A; Tiffin N; Khomo N; Leslie J; Boulle A; Mudaly V; Kock Y; Meintjes G; Wasserman S Clin Infect Dis; 2019 Apr; 68(9):1522-1529. PubMed ID: 30165431 [TBL] [Abstract][Full Text] [Related]
35. Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study. Schnippel K; Ndjeka N; Maartens G; Meintjes G; Master I; Ismail N; Hughes J; Ferreira H; Padanilam X; Romero R; Te Riele J; Conradie F Lancet Respir Med; 2018 Sep; 6(9):699-706. PubMed ID: 30001994 [TBL] [Abstract][Full Text] [Related]
36. Bedaquiline for the treatment of pulmonary, multidrug-resistant tuberculosis in adults. Gras J Drugs Today (Barc); 2013 Jun; 49(6):353-61. PubMed ID: 23807939 [TBL] [Abstract][Full Text] [Related]
37. Acquired Resistance to Bedaquiline and Delamanid in Therapy for Tuberculosis. Bloemberg GV; Keller PM; Stucki D; Trauner A; Borrell S; Latshang T; Coscolla M; Rothe T; Hömke R; Ritter C; Feldmann J; Schulthess B; Gagneux S; Böttger EC N Engl J Med; 2015 Nov; 373(20):1986-8. PubMed ID: 26559594 [TBL] [Abstract][Full Text] [Related]
38. Bedaquiline: a new hope to treat multi-drug resistant tuberculosis. Patel RV; Riyaz SD; Park SW Curr Top Med Chem; 2014; 14(16):1866-74. PubMed ID: 25262806 [TBL] [Abstract][Full Text] [Related]
39. Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study. Ferlazzo G; Mohr E; Laxmeshwar C; Hewison C; Hughes J; Jonckheere S; Khachatryan N; De Avezedo V; Egazaryan L; Shroufi A; Kalon S; Cox H; Furin J; Isaakidis P Lancet Infect Dis; 2018 May; 18(5):536-544. PubMed ID: 29452942 [TBL] [Abstract][Full Text] [Related]
40. Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis? Guglielmetti L; Le Dû D; Veziris N; Caumes E; Marigot-Outtandy D; Yazdanpanah Y; Robert J; Fréchet-Jachym M; Eur Respir J; 2016 Aug; 48(2):582-5. PubMed ID: 27338196 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]